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INTRODUCTION

This article will explore the potential pitfalls of using certain claim types for
protection of computerized systems or devices that include functionality enabled
software. Through a demonstration of the potential shortcomings of method
claims, particularly in the area of damages awarded, it will discuss why a
computer-readable medium claim may be a good alternative to a standard method
claim. 1 In addition, it will illustrate how a computer-readable medium claim can
provide a claim scope similar to a method claim without having to prove actual
use to obtain damages. 2
Attached to the end of this article are three appendices. Appendix A portrays
statistical analysis of the use of Beauregard claims, while Appendices B and C
respectively provide an overview of basic claim types used within patent
applications and types of patent infringement.
A. Background
Today’s economy has become very dependent on computer software because
of the role it plays in nearly everything we do, from simple everyday tasks all the
way up to our nation’s complex infrastructure. 3 The increased reliance on
computers and computer programs powering electronic devices is accompanied
by a desire to patent those programs. Patentability of software has been a sticking
point for the courts and the United States Patent and Trademark Office
(“USPTO”) for many years. 4 In 1995, the USPTO responded to the emergence of
computer software and began allowing computer-readable medium claims. 5 In
the years that have followed, however, patents focused on computerized devices
have often been written by claiming “a process” in what are commonly referred to
as method claims. 6
1

See infra text accompanying notes 41-77.
See infra text accompanying notes 54-69.
3
See, e.g., U.S. CENSUS BUREAU, Internet Use in the United States: October 2009,
http://www.census.gov/hhes/computer/ (last visited July 18, 2011) (revealing that 68.7% of all
householders (defined as the person (or one of the persons) in whose name the housing unit is
owned or rented) reported using the internet at home, and 76.7% reported using the internet from
some location (either inside or outside the home)).
4
See Andrei Iancu & Jeremiah Helm, Code on Disks and Hat Tricks – Is Computer Software
on a Medium Really Patentable?, 90 J. PAT. & TRADEMARK OFF. SOC’Y 97, 97 (2008); see also
U.S. PATENT & TRADEMARK OFFICE, U.S. DEP’T OF COMMERCE, MPEP § 2106.01 (8th ed. Rev. 8,
July 2010) (discussing computer-related nonstatutory subject matter).
5
See In re Beauregard, 53 F.3d 1583 (Fed. Cir. 1995).
6
See 1 R. CARL MOY, MOY’S WALKER ON PATENTS § 5.35 (4th ed. 2010) (discussing general
patentability of computer related inventions).
2
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Because of the potential for enormous sums of money, the recovery of
damages has become one of the most important aspects of a patent. 7 Since the
Supreme Court’s decision in eBay, Inc. v. MercExchange, L.L.C., 8 the ability for a
patent owner to obtain an injunction to stop an infringer from conducting the
infringing behavior has been limited. 9
Accordingly, patent claims that provide a patent owner the best opportunity to
recover damages are increasingly important. Recent cases involving computerized
devices highlight potential pitfalls in relying on claiming methods of operation
(e.g., method claims) to cover devices or systems. 10 In order for a method claim
to be infringed, all steps of the process must be carried out. 11 As a result, patent
holders may be losing out on a portion of the damages to which they are entitled
when a device is merely capable of infringement. 12 When asserting a method
claim against a system or device that is capable of infringing, the patent owner
will only be able to recover damages for those systems or devices shown to have
actually performed the claimed method. 13 In a world of programmable devices,
those devices that have been programmed to actually perform the claimed method
may be far fewer than those devices including software providing the capability to
perform the claimed method.
Moreover, these issues are not limited only to computer software. For
example, medical device manufacturers spend a great deal of time and money
developing, testing, and marketing products.
Accordingly, strong patent
protection for unique features of a medical device can help provide competitive
advantages in this industry. 14 Modern medical devices include electromechanical
devices that can contain embedded software. In an infringement suit that only
asserts method claims, the device (e.g., embedded software) must have executed
the claimed method or it will not have been found to infringe. 15

7

See z4 Techs., Inc. v. Microsoft Corp., 434 F. Supp.2d 437, 438-39 (E.D. Tex.
2006)(damages of $115 million awarded against Microsoft and $18 million against Autodesk); see
infra 46-51 and discussion.
8
547 U.S. 388 (2006).
9
See Id. at 393.
10
See Finjan, Inc. v. Secure Computing Corp., 626 F.3d 1197 (Fed. Cir. 2010); Cardiac
Pacemakers, Inc. v. St. Jude Med., Inc., 576 F.3d 1348 (Fed. Cir. 2009).
11
See Lucent Techs. v. Gateway, Inc., 580 F.3d 1301, 1317 (Fed. Cir. 2009); see also Joy
Techs., Inc. v. Flakt, Inc., 6 F.3d 770, 775 (Fed. Cir. 1993).
12
See Cardiac Pacemakers, Inc., 576 F.3d at 1358-59.
13
See Lucent Techs., 580 F.3d at 1317.
14
E.g., the ability to keep a competitor from exploiting the invention or the generate revenue
through a licensing agreement.
15
See Cardiac Pacemakers, Inc., 576 F.3d at 1354.
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SHORTCOMINGS OF VARIOUS CLAIMS IN PROTECTING SYSTEMS OR DEVICES

Computerized systems or devices have become commonplace in the last
few decades. As a result, companies that design and manufacture such devices
have increasingly sought out patent protection for the computerized aspects of
these systems or devices. 16 An excellent example of computerization can be seen
in the development of implantable medical devices, such as pacemakers. A large
number of medical devices on the market today are a mixture of both hardware
and software. 17
Patents written to protect the intellectual property embodied within medical
devices (or any computerized system) typically include a mixture of method and
system claims. 18 It is not uncommon for the method claims to represent, at least
facially, the broadest scope of coverage. 19 By only focusing on method claims to
protect their intellectual property, device manufacturers may not be protecting
themselves fully when the patented device is infringed. 20 For example, in
Cardiac, the plaintiff had its damages drastically reduced during an appeal to the
Federal Circuit in 2009 due to the infringement requirements of method claims. 21
The dispute between Cardiac and St. Jude centered on an implantable
cardioverter defibrillator (“ICD”). 22 “ICDs are small devices that detect and
correct abnormal heart rhythms that can be fatal if left untreated.” 23 The ICDs are
implantable cardiac devices that can be programmed to administer different types
of electrical shocks. 24 The patent in question 25 claimed a method of heart
stimulation using an implantable heart stimulator that is capable of detecting heart
arrhythmias or irregular heart rhythms, and of being programmed to treat the
arrhythmia through either single or multimode operation. 26

16
U.S. PATENT & TRADEMARK OFFICE, PATENT TECHNOLOGY MONITORING TEAM (PTMT),
Patenting by Organizations (2010)(IBM was granted 5,866 patents in 2010 and the Microsoft
Corporation received 3086 patents.)
17
An implantable cardioverter defibrillator is one example. See infra discussion notes 22-24
18
See U.S. Patent No. 4,407,288 (filed Mar. 16, 1981). See infra text accompanying notes 2529
19
E.g., the ‘288 patent at issue in Cardiac where the protection was derived from a method
claim, and the system claim was dropped.
20
See Cardiac Pacemakers, Inc., 576 F.3d at 1354.
21
Id. at 1358.
22
Id. at 1351.
23
Id. at 1352.
24
Id.
25
U.S. Patent No. 4,407,288 (filed Mar. 16, 1981).
26
Cardiac Pacemakers, Inc., 576 F.3d at 1352.
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The patent was held to be valid and infringed, so the focus turned to a
determination of damages. 27 The district court granted St. Jude's motion to limit
damages to ICDs that actually performed the claimed steps. 28 This is where
asserting only a method claim fell short.
Originally the jury was presented with two claims: an apparatus claim, and a
method claim. 29 During litigation, the plaintiff abandoned the apparatus claim.30
The apparatus claim, if infringed, may have provided the plaintiff with a better
basis to maintain their original damages award for all devices sold with the
capability of performing in a manner that infringed the claims. 31 However, by
dropping the assertion of infringement of the apparatus (e.g., system) claim, the
plaintiff was left with damages limited to only those devices that had actually
been user-programmed to perform the patented method, rather than damages for
all devices sold that infringed on the apparatus claim by being user-programmable
to provide the functionality to infringe the apparatus claim. 32
The plaintiff sought royalties for infringement of its method claim. 33 The
problem that the plaintiff faced was that “a method claim is directly infringed
only by one practicing the patented method.” 34 Additionally, the court held that
“the sale of the apparatus is not the sale of the method. A method claim is
directly infringed only by one practicing the patented method.” 35 As a result, the
plaintiff was unable to retain damages for royalties on those devices that were
sold and merely capable of completing the process. 36 The damages finally

27
28

Id. at 1351.
Cardiac Pacemakers, Inc. v. St. Jude Med., Inc., 418 F.Supp.2d 1021, 1040 (S.D. Ind.

2006).
29

Cardiac Pacemakers, Inc., 576 F.3d at 1358.
See Cardiac Pacemakers, Inc. v. St. Jude Med., Inc., 381 F.3d 1371, 1380-83 (Fed. Cir.
2004). Cardiac had originally asserted two claims in the 4,407,288 patent. Id. The jury initially
returned a verdict of valid claims that were not infringed by St. Jude. Id. Cardiac only appealed
the method claim arguing that it was incorrectly construed and the jury was therefore given
improper instructions with respect to infringement. Id. At this point in the trial, Cardiac
discontinued pursuit of the apparatus claim. Id.
31
See Cardiac Pacemakers Inc., 576 F.3d at 1358.
32
Id.
33
Id. at 1359.
34
Id. at 1359 (citing Joy Techs. v. Flakt, Inc., 6 F.3d 770 (Fed. Cir. 1993)). In Joy
Technologies the court held that sales of equipment capable of performing a patented process were
not direct infringement. Id. at 744-75. Method patents used in areas other than software must
fulfill the same requirements. Sale of equipment capable of performing a process is only an issue
when that process is actually executed since it is the process, not the apparatus that is patented. Id.
35
Joy Techs., 6 F.3d at 775.
36
Cardiac Pacemakers, Inc., 576 F.3d at 1366.
30
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obtained by the plaintiff were limited to those devices that actually performed the
patented method during the relevant infringement period. 37
It is interesting to note that the apparatus claim was not pursued on appeal in
Cardiac. 38 It is not entirely clear from the case history why this is so, but the
petitioner’s brief on appeal only requests the court to either apply the jury’s
damage award or allow for a new trial due to the incorrect interpretation of claim
4 (a method claim) of the ‘288 Patent. 39 The petitioners did not discuss any issue
with the apparatus claim. 40 Potentially this could result from the fact that even
though the software of the accused devices may have infringed the hardware, the
defendant's manufactured product did not meet the limitations of claim 13 of the
‘288 patent.
III.
BEAUREGARD CLAIMS AS AN ALTERNATIVE
Beauregard claims are a viable alternative to method and apparatus claims
for protection of intellectual property embodied within computerized systems or
devices. Recent Federal Circuit decisions provide legitimacy to assertion of
Beauregard claims as well as areas of caution with using Beauregard claims for
protection of computerized systems and devices (e.g., medical devices). 41
A.

Successful Assertion of a Beauregard Claim

Beauregard claims can be included in a patent to provide protection for
computerized systems or devices by claiming executable instructions contained
on a computer-readable medium that cause the system or device to perform a
certain function. 42 As a result, the patent holder can pursue infringement charges
against other manufacturers as direct infringers without having to show actual
use. 43 Additionally, the patentee can recover damages from the manufacturer for
sales of the actual system or device that directly infringe without having to prove
indirect infringement (i.e., where a user must perform the claimed method). 44 By
using a Beauregard claim instead of an apparatus claim, the patent holder can

37

See id. at 1359.
See id. at 1380-83.
39
Brief of Plaintiff-Appellant at 55, Cardiac Pacemakers, Inc. v. St. Jude Med., Inc., 381 F.3d
1371 (Fed. Cir. 2004) (Nos. 02-1532, 02-1559).
40
See id.
41
See infra text accompanying notes 42-95.
42
See, e.g., Ex parte Bo Li, No. 2008-1213 (B.P.A.I. Nov. 6, 2008) (finding a typical
Beauregard claim to be statutory subject matter).
43
Finjan, Inc. v. Secure Computing Corp., 626 F.3d 1197 (Fed. Cir. 2010).
44
Id. at 1212.
38
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focus on proving functionality not proving that an infringing device includes
structure analogous to the structure recited by an apparatus claim. 45
In 2007, the Federal Circuit affirmed a jury verdict that granted z4
Technologies, Inc. (“z4”) $115 million in damages against the Microsoft
Corporation (“Microsoft”) and $18 million in damages against Autodesk, Inc.
(“Autodesk”). 46 One of the claims asserted by z4 was the Beauregard claim
reproduced below. 47 z4 accused both Microsoft and Autodesk of infringing claim
32 of United States Patent 6,044,471. 48 The claim states:
A computer readable storage medium having data stored therein
representing software executable by a computer, the software
including instructions to reduce use of the software by
unauthorized users, the storage medium comprising: instructions
for requiring a password associated with the software; instructions
for enabling the software after the password has been
communicated to the software; instructions for subsequently
requiring a new password to be communicated to the software for
continued operation of the software; and instructions for
automatically contacting an authorized representative of the
software to communicate registration information and obtaining
authorization for continued operation of the software. 49
This is a prototypical Beauregard claim, as evidenced by the language at the
preamble of the claim. During the jury trial, the jury returned a verdict of willful
infringement by Microsoft and Autodesk and awarded damages of $115 million
and $18 million respectively. 50 Microsoft challenged the validity of the patents,
but the district court held them to be valid and enforceable. 51 The court's finding
that the '471 Patent was valid and enforceable supported the notion that
Beauregard claims are a valid tool in writing claims for patents that include
software. 52 The validity of Beauregard claims do not appear to have been
45

Id. at 1205.
z4 Techs., Inc. v. Microsoft Corp., 507 F.3d 1340, 1356 (Fed. Cir. 2007).
47
Id. at 1345.
48
U.S. Patent No. 6,044,471 (filed June 4, 1998).
49
Id.
50
z4 Techs., Inc., 507 F.3d at 1346.
51
Id.
52
See id.; see also Creative Internet Advert. Corp. v. Yahoo! Inc., No. 6:0704354, 2009 WL
2382132, at *1 (E.D. Tex. 2009). The Creative Internet Advertising Corp. asserted infringement
by Yahoo! Inc. of claim 45 of U.S. Patent 6,205,432 (filed Nov. 16, 1998) which was a
Beauregard-style claim. Id. at *1. The U.S. District Court for the Eastern District of Texas
upheld the jury verdict. Id.
46
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seriously disputed within the courts since being recognized as statutory subject
matter by the USPTO in 1995. 53
In a more recent case, Finjan, Inc. v. Secure Computing Corp., the Federal
Circuit upheld a jury finding of infringement for the sale of software that was
capable of infringing, even though the infringing features were disabled. 54 In
Finjan, the plaintiff sued for infringement of United States Patents Nos. 6,092,194
(“’194 Patent”), 55 6,804,780 (“’780 Patent”), 56 and 7,058,822 (“’822 Patent”). 57
Each of the patents contains both method and system claims. In addition, the ‘780
Patent and the ‘194 Patent include computer-readable storage medium claims. 58
In a jury trial, the district court held that the defendant willfully infringed all
asserted claims of the plaintiff’s patents. 59 The defendant sold three allegedly
infringing products, each of which included multiple modules that required the
separate purchase of an activation key by the end-user. 60 The defense argued that
its software, as delivered, did not infringe because the potentially infringing
software was not activated. 61 However, the Federal Circuit disagreed, at least in
regard to the system and computer-readable storage medium claims asserted by
the plaintiff. 62 For example, claim 65 of the ‘194 Patent recited a computerreadable storage medium. 63 The Federal Circuit stated that there was nothing in
the statement of claim 65 that “require[s] program code be ‘active’, only that it be
written ‘for causing’ a server (‘194 patent claim 65) . . . to perform certain
steps.” 64 The Federal Circuit made it quite clear that the deciding question is
whether the capability is present within the code, not whether that code is actually
active or even used. 65
By asserting Beauregard-style claims, the plaintiff in Finjan was able to
secure a finding of direct infringement simply by convincing the jury that the
defendant shipped software that included the capability of performing infringing
53

See In re Beauregard, 53 F.3d 1583, 1584 (Fed. Cir. 1995). A check of cases citing to this
case reveals only three cases as of the date this article was written.
54
626 F.3d 1197, 1203-1205 (Fed. Cir. 2010).
55
U.S. Patent No. 6,092,194 (filed Nov. 6, 1997).
56
U.S. Patent No. 6,804,780 (filed Mar. 30, 2000).
57
U.S. Patent No. 7,058,822 (filed May 17, 2001).
58
Finjan, 626 F.3d at 1201.
59
Id. at 1200.
60
Id. at 1202.
61
Id. at 1203.
62
Id. at 1203-05.
63
Id. at 1205. See also U.S. Patent No. 6,092,194 cl. 65 (filed Nov. 6, 1997) (claiming a
“computer-readable storage medium storing program code for causing a server that serves as a
gateway to a client to perform the steps of . . . .”).
64
Finjan, 626 F.3d at 1205.
65
Id.
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functions. 66 In reference to both system and computer-readable medium claims,
the Court stated “we have held that, to infringe a claim that recites capability and
not actual operation, an accused device ‘need only be capable of operating’ in the
described mode.” 67 Additionally, the Federal Circuit held that “an accused device
may be found to infringe if it is reasonably capable of satisfying the claim
limitations, even though it may also be capable of noninfringing modes of
operation.” 68 The Finjan decision, which was approximately six months old at
the time of this writing, is further proof that Beauregard-type claims can provide
enhanced protection for computerized systems or devices when compared to an
equivalent method claim.
As noted within the Finjan case, apparatus claims can also be successfully
asserted against devices or systems that are merely capable of infringing. 69
However, apparatus claims must include structural or means-plus-function
elements that limit application of the claim to potentially infringing devices.70
For example, it would appear from the history of the Cardiac case, discussed
above, 71 that the originally asserted apparatus claim included some form of
structure not necessarily present in the accused devices. 72 If an apparatus claim is
written in means-plus-function form, the claim itself can be, at least facially,
focused on functional operations. 73 However, it is well known that means-plusfunction claims are narrowly construed to only cover the structure (and
equivalents) discussed within the specification as being capable of performing the
recited functional operations. 74 Thus, apparatus claims are limited by structure,
while method and Beauregard type claims need not be so limited.
Medical devices such as the ICDs that were at issue in Cardiac 75 typically
contain memory with embedded software code. The memory that is contained in
the medical device is a medium upon which computer executable code is being
66

Id.
Id. at 1204 (citing Intel Corp. v. U.S. Int’l Trade Comm’n, 946 F.2d 821, 832 (Fed. Cir.
1991)).
68
Finjan, 626 F.3d at 1204 (citing Hilgraeve Corp. v. Symantec Corp., 265 F.3d 1336, 1343
(Fed. Cir. 2001)).
69
See Finjan, 626 F.3d at 1203-05.
70
Id.
71
Supra text accompanying notes 21-40.
72
Id. See also generally Cardiac Pacemakers, Inc. v. St. Jude Med., Inc., 381 F.3d 1371,
1380-83 (Fed. Cir. 2004); Brief of Plaintiff-Appellant at 55, Cardiac Pacemakers, Inc. v. St. Jude
Med., Inc., 381 F.3d 1371 (Fed. Cir. 2004) (Nos. 02-1532, 02-1559). This case is used as an
example only. The record does not clarify the exact reasons for not pursuing the apparatus claim.
73
Cite – or provide example
74
See 35 U.S.C. § 112, ¶ 6(2006); In re Donaldson Co., Inc, 16 F.3d 1189, 1193 (Fed. Cir.
1994)(en banc).
75
576 F.3d 1348 (Fed. Cir. 2009); see also supra notes 21-40 and accompanying text.
67
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stored (i.e., a computer-readable medium). As a result, such medical device
patents can be written utilizing Beauregard claims rather than just method and
apparatus claims. By patenting the software on a tangible medium, rather than
patenting the software as an intangible process, patent holders may be able to
avoid limiting damages. 76 Yet, a Beauregard style claim can capture scope that is
often, at least arguably, as broad as a similar method claim. In Cardiac, if the
claim at issue had been a Beauregard claim reciting similar functional operations,
then the plaintiff may not have been limited to damages for only those devices
that could be shown to have actually performed the process. 77 On the contrary,
the plaintiff may have been able to collect damages from St. Jude as a direct
infringer for every device that was sold that contained the set of software
instructions capable of infringing the protected functionality.
B.

Question of Validity

The validity of Beauregard claims has generally not been litigated in the years
since the Federal Circuit affirmed the USPTO decision to make computerreadable medium statutory subject matter in In re Beauregard. 78 One case in
particular Cybersource Corp. v. Retail Decisions, Inc., 79 one of the few cases that
cites back to In re Beauregard, 80 questioned the validity of the Beauregard
holding itself. 81 The Cybersource court stated that the “footing of the so-called
Beauregard doctrine is anything but sure.” 82 While this is a note of caution to the
use of Beauregard claims, the lack of other litigation on validity implicates the
opposite conclusion. 83 More specifically, patent holders are asserting Beauregard
claims, 84 and the claims are being litigated to successful conclusions. 85 The only
major claim-related issue with the litigation asserting Beauregard-type claims
seems to be focusing on general claim construction issues that have no relation to
the fact that the claims are Beauregard claims. 86
76

See Finjan, 626 F.3d at 1197. See supra text accompanying notes 54-74.
As discussed throughout the paper, the plaintiff would not have had to prove execution of
the method, just sale of the ICD if using a Beauregard claim to obtain the protection instead of a
method claim.
78
53 F.3d 1583 (Fed. Cir. 1995).
79
620 F.Supp.2d 1068 (N.D. Cal. 2009).
80
53 F.3d 1583 (Fed. Cir. 1995).
81
See Cybersource, 620 F.Supp.2d at 1078-79.
82
Id. at 1079.
83
See z4 Techs., Inc. v. Microsoft Corp., 507 F.3d 1340 (Fed. Cir. 2007); Finjan, Inc. v.
Secure Computing Corp., 626 F.3d 1197, 1205 (Fed. Cir. 2010).
84
See, e.g., Finjan, 626 F.3d 1197. See also infra app. A.
85
For examples of cases that include successful assertion of Beauregard claims with multimillion dollar damage awards, see z4 Techs., 507 F.3d 1340; Finjan, 626 F.3d at 1205.
86
See Oracle Corp. v. Parallel Networks, L.L.C., 375 Fed.Appx. 36, 2010 WL 1709308 (Fed.
Cir. 2010). The Court of Appeals reversed a summary judgment finding by the district court which
77
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The lack of litigation directly attacking Beauregard claims is a positive sign.
The court in Cybersource suggested that the footing of Beauregard claims was
unsure, 87 making any litigation potentially troublesome. However, the absence of
such litigation suggests that these claims are valid and are not being challenged on
the basis of citing non-statutory subject matter. The only caveat with using this
method of claiming, as evidenced by the litigation, is that the claim must be
properly constructed. 88 This is nothing new in practice, however, since the
language of any claim must be carefully chosen to provide the most protection
while safeguarding against the risk of invalidation during litigation. The mere
fact that it is a Beauregard claim apparently does not add to that issue.
C.

Assertion as a Dependent Claim

While Beauregard claims are generally inserted as independent claims, they
can also be inserted into a patent as dependent claims. 89 In Schumer v.
Laboratory Computer Systems, Inc., the Court of Appeals for the Federal Circuit
overturned the district court's decision to treat a dependent Beauregard claim as
invalid because the independent claim was determined to be invalid. 90 The court
reasoned that “when determining the validity of the claims of a patent, each claim
must be separately considered.” 91 The Schumer court based its decision on the
idea that:
Each claim of a patent (whether in independent, dependent, or
multiple dependent form) shall be presumed valid independently of
the validity of other claims; dependent or multiple dependent
claims shall be presumed valid even though dependent upon an
invalid claim.... The burden of establishing invalidity of a patent or
any claim thereof shall rest on the party asserting invalidity. 92
Since a claim is scrutinized on its own it is important that the claim be
carefully constructed. If not, the issue that arises is one that came up in IPXL
had found in favor of non-infringement. One of the claims asserted was a Beauregard claim, but
the litigation focused on specific interpretation of a limitation within the claim. Id. See also IEX
Corp. v. Blue Pumpkin Software, Inc., 122 Fed.Appx. 458 (Fed. Cir. 2005); Sw. Tech.
Innovations, LLC v. Symantec Corp., C-09-1063 MMC, 2010 WL 1729405 (N.D. Cal. 2010);
Irise v. Axure Software Solutions, Inc., CV 08-03601 SJO, 2009 WL 3615075 at *36 (C.D. Cal.
2009).
87
Cybersource Corp. v. Retail Decisions, Inc., 620 F.Supp.2d 1068 (N.D. Cal. 2009).
88
See generally IEX Corp., 122 Fed.Appx. at 464 (following the standard procedures for
claim construction and carefully analyzing the claim’s language).
89
See Schumer v. Lab. Computer Sys., Inc., 308 F.3d 1304 (Fed. Cir. 2002).
90
Id.
91
Id. at 1316.
92
Id. (citing 35 U.S.C. § 282 (2000)).
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Holdings, LLC v. Amazon.com, Inc. 93 In IPXL, the court held invalid a method
claim that was dependent to a system claim because it was indefinite. 94 The court
held that drafting claims in this manner is indefinite because it is unclear whether
infringement occurred when the system was created or when the method was
actually executed. 95 In light of the IPXL holding it is better practice to write
Beauregard claims as independent claims, rather than as dependent claims.
IV.

CONCLUSION

Method claims are used commonly in patents for software and computerized
systems and devices. Medical devices that include embedded software are often
patented using both method claims and apparatus claims. In an infringement suit,
however, where the method claim is at issue and not the apparatus claim, patent
holders risk losing a portion of the damages to which they are entitled. It is clear
that a properly drafted patent should cover a device that is merely capable of
infringement when it comes to calculating damages or obtaining an injunction.
To accomplish this, Beauregard claims can be used in patents covering these
electromechanical devices so that any sale of a device would qualify as
infringement. By including Beauregard claims in device patents, patent holders
can enhance the protection of their intellectual property.

93

IPXL Holdings, LLC v. Amazon.com, Inc., 430 F.3d 1377 (Fed. Cir. 2005).
Id.
95
Id. at 1384.
94
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APPENDIX A: BEAUREGARD CLAIM TREND INFORMATION
A.

Application Statistics

In the immediate period after In re Beauregard 96 there was an abundant
growth in the use of this style of claims. The growth, however, has dropped off
significantly in the last five years. The last five years have seen a decline to a
level that is similar to what it was in the period immediately following the case
(See Figure 1).

Figure 1 – The Calculated Number of Patent Applications Containing
Beauregard Claims Between 1996 and 2010
A method for pulling statistics had to be created in order to determine the
frequency at which practitioners are submitting patent applications that include
Beauregard claims. The United States Patent office has a database that can be
queried for specific language in the claims. The time ranges were queried using
claim language that is typical in a Beauregard claim and the results from each
96

53 F.3d 1583 (Fed. Cir. 1995).
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phase were combined to obtain the number of patents over each five-year period
that contained these claims (See Table 1).
Search Phrase
computer readable medium

computer-readable medium

computer readable media

computer-readable media
computer readable storage
medium
computer-readable storage
medium
computer readable storage
media
computer-readable storage
media

Date Range
1996-2000
2000-2005
2005-2010
1996-2000
2000-2005
2005-2010
1996-2000
2000-2005
2005-2010
1996-2000
2000-2005
2005-2010
1996-2000
2000-2005
2005-2010
1996-2000
2000-2005
2005-2010
1996-2000
2000-2005
2005-2010
1996-2000
2000-2005
2005-2010

Number of
Patents
9785
28780
10713
5096
13609
5081
728
3225
1277
320
1691
713
2502
9865
6489
1297
5632
3713
125
827
650
47
460
429

Table 1 – Breakdown of Search Phrases by Time Range and Resulting
Number of Patent Applications
B.

Markman Hearing and Litigation Statistics

There has been a limited amount of litigation of Beauregard claims in the
fifteen years since the decision was made. In order to track the frequency with
which Beauregard claims have been both asserted and litigated, a method of
tracking was created. Figure 2 shows a breakdown of the number of Markman 97
97

See Markman v. Westview Instruments Inc., 52 F.3d 967 (Fed. Cir. 1995).
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hearings on a yearly basis, compared with the number of cases that have been
litigated over the past fifteen years. The search was based on Westlaw results on
a query that was run for each year. 98 The majority of the cases were decided in
2008 and 2009.

Figure 2 – Number of Markman Hearings and Trials for Patents Containing
Beauregard Claims

98

The following search string was used: “(READABLE +2 MEDI!) & da(aft 1/1/1996 & bef
12/31/1996).” The dates were adjusted and ran for each year between 1995 and 2010. The query
was run in the Westlaw database containing only Markman hearings and then again in the Federal
IP cases database to determine the number of cases being litigated.
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APPENDIX B: BASIC CLAIM TYPES
The United States Patent Act provides that an inventor may receive a patent
for any new and useful process, machine, manufacture, or composition of
matter. 99 Descriptions of the different ways to claim devices that contain both
software and hardware follow.
A.

Method Claims

A method claim is used to reduce an invention to a series of steps or acts for
performing a function to accomplish a result. The Supreme Court held that a
method, or process, is a mode of treatment of certain materials to produce a given
result. 100 Method claims define the invention in terms of what it does, or how it is
done, as opposed to its structural definition. 101 Method claims are ideal for
patenting an invention that does not have a unique apparatus but still completes a
unique process. Because method claims focus on function rather than structure
they are often the broadest type of claim that can be used for patenting
software. 102
B.

Apparatus Claims

Apparatus claims are those claims that are tied directly to a device. A typical
apparatus claim describes the invention in terms of its components. In this sense
it is described in terms of what it is, not what it does. 103 A more limiting type of
apparatus claim is the means-plus-function apparatus claim. These claims
describe the device in terms of what it does, not what it is. 104 Apparatus claims
are typically included along with method claims when there are both hardware
and software components to an invention. 105
C.

Computer-Readable Medium Claims

Computer-readable medium claims are also known as Beauregard claims.106
This type of claim allows for patenting software that is embedded onto a
“computer-readable medium” such as a disk, CD, or other medium. By using a
Beauregard claim, the patent-holder protects itself from other manufacturers as
99

35 U.S.C. § 101 (2006).
Gottschalk v. Benson, 409 U.S. 63, 70 (1972).
101
STEVEN W. LUNDBERG & STEPHEN C. DURANT, ELECTRONIC AND SOFTWARE PATENTS:
LAW AND PRACTICE 6-16 (2nd ed. 2005).
102
Id. at 6-28.
103
Id. at 6-16.
104
Id.
105
Id. at 6-29.
106
See In re Beauregard, 53 F.3d 1583 (Fed. Cir. 1995).
100
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direct infringers rather than as contributory infringers. This actually allows a
software manufacturer to collect damages for infringement from a distributor of
the computer-readable medium, rather than going after the end-user who is
executing the software, which is often impractical or even impossible.
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APPENDIX C: TYPES OF INFRINGEMENT
Section 271 of the Patent Act defines the various types of patent
infringement. 107 A patent holder can accuse an infringer of violating its patent
rights in three different ways: (1) directly infringing; (2) inducing infringement;
or (3) contributing to infringement.
A.

Direct Infringement
“Direct infringement” is defined as:
[W]hoever without authority makes, uses, offers to sell, or sells any
patented invention, within the United States or imports into the United
States any patented invention during the term of the patent therefor,
infringes the patent. 108

Under this rule, the patentee may bring an action against a defendant who
commits acts that infringe. “The making, using, or selling of a patented invention
is the usual meaning of the expression 'direct infringement'.” 109 However, when
infringement is asserted for a patent that contains only method claims there is a
different standard that must be followed. “Method claims are only infringed
when the claimed process is performed, not by the sale of an apparatus that is
capable of infringing use." 110 Thus the direct infringement of method claims
happens when the end-user fully executes the process, and does not happen
simply when the manufacturer sells a device that is capable of infringing.
B.

Indirect Infringement

A patent holder may also sue for indirect infringement. There are two
different types of indirect infringement: inducing infringement and contributory
infringement. They are defined by 35 U.S.C. subsections 271(b) and (c)
respectively. Indirect infringement (both inducing and contributory) is dependent
on direct infringement existing as well. 111
1.

Inducing Infringement

Inducement of infringement is defined as “[w]hoever actively induces
infringement of a patent shall be liable as an infringer.” 112 In addition to direct
107

See 35 U.S.C. § 271 (2006).
35 U.S.C § 271(a) (2006).
109
Joy Techs., Inc. v. Flakt, Inc., 6 F.3d 770, 773 (Fed. Cir. 1993).
110
Ormco Corp. v. Align Tech., Inc., 463 F.3d 1299, 1311 (Fed. Cir. 2006).
111
See Standard Havens Prods., Inc. v. Gencor Indus., Inc., 953 F.2d 1360, 1374 (Fed. Cir.
1991).
112
35 U.S.C. § 271(b) (2006).
108
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infringement, for inducement of infringement there must be proof that the accused
party actively and knowingly assisted an act of direct infringement. 113 In a recent
case, the Federal Circuit further held that an agency relationship or a contractual
obligation to perform the claimed steps is required for two parties to be held
jointly liable when the claim infringed is a method claim. 114
2.

Contributory Infringement

Contributory infringement is defined as:
Whoever offers to sell or sells within the United States or imports
into the United States a component of a patented machine,
manufacture, combination or composition, or a material or apparatus
for use in practicing a patented process, constituting a material part of
the invention, knowing the same to be especially made or especially
adapted for use in an infringement of such patent, and not a staple
article or commodity of commerce suitable for substantial
noninfringing use, shall be liable as a contributory infringer. 115
In order to prove contributory infringement, a patentee must prove that the
defendant knew that the product was specifically made for use in infringing the
patented method, and that the product sold to the direct infringer was a material
part of the invention. 116

113
114

Water Techs. Corp. v. Calco, Ltd., 850 F.2d 660, 668 (Fed. Cir. 1988).
See Akamai Techs., Inc. v. Limelight Networks, Inc., 629 F.3d 1311, 1320 (Fed. Cir.

2010).
115
116

2008).

35 U.S.C. § 271(c) (2006).
See Veritas Operating Corp. v. Microsoft Corp., 562 F.Supp.2d 1141, 1157 (W.D. Wash.

